ubs prprty fd leman resd fon
(FONC:SIX Swiss Ex)
Former Director, Member of Human Resources & Compensation Committee and Member of Governance & Nominating Committee, UBS Group AG
|Age||Total Calculated Compensation||This person is connected to 98 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Mr. Ernesto Bertarelli serves as Vice President at Emerging Biopharmaceutical Enterprises. Previously, Mr. Bertarelli served as the Chief Executive Officer of Merck Serono S. A. from January 1996 to January 9, 2007 and its Managing Director, Director, and Member of Executive Management Board until January 9, 2007. Mr. Bertarelli began his career at Merck Serono S.A. in 1985, where he has held several positions of increasing responsibility in Sales and Marketing. He served ...
Bahnhofstrasse 45Phone: 41 44 234 11 11
Zurich, Zurich 8001
Fax: 41 44 239 91 11
Board Members Memberships*
Former Vice Chairman, Chief Executive Officer, Managing Director and Member of Executive Management Board
Chairman Of the Board
Former Director, Member of Human Resources & Compensation Committee and Member of Governance & Nominating Committee
Harvard Business School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Roberto Egydio Setubal||Vice Chairman, Chief Executive Officer, President, Chairman of Nomination & Corporate Governance Committee, Member of Capital & Risks Management Committee, Member of Strategy Committee and Member of Personnel Committee|
Itaú Unibanco Holding S.A.
|Bart De Smet||Chief Executive Officer and Executive Director|
|Luiz Carlos Trabuco Cappi||Vice-Chairman, Chief Executive Officer and Member of Compensation Committee|
Banco Bradesco S.A.
|John D. Neal||Group Chief Executive Officer and Executive Director|
QBE Insurance Group Limited
|Craig Duncan Meller||Chief Executive Officer, Managing Director and Director|
|A$3.1M||Compensation as of Fiscal Year --.|